Challenging the concept that late recurrence and death from tumor are common after fractionated radiotherapy for benign meningioma

Based on national meeting presentations and prominent journal articles, there is major controversy about the curability of benign meningioma and the value of long-term follow-up [1,2]. The view that benign meningioma is a highly curable tumor stems from the many reports of high ( ∼90%) control rates at 5 years after gross total resection or radiotherapy. The contradictory opinion derives from a small number of studies—mainly Scandinavian—that report high recurrence rates with very long-term follow-up.

Source: Radiotherapy and Oncology - May 5, 2019 Category: Radiology Authors: Lillie O'steen, Robert J. Amdur, Christopher G. Morris, William M. Mendenhall Tags: Original Article Source Type: research